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Objectives: This study was undertaken to examine the long-term results of surgery
for aortic root aneurysm in patients with Marfan syndrome.
Methods: Forty-four patients underwent aortic root replacement and 61 underwent
aortic valve-sparing operations for aortic root aneurysm. Patients who underwent
aortic root replacement had more severe symptoms, worse left ventricular function,
more severe aortic insufficiency, and larger aortic root aneurysms than did patients
who had aortic valve-sparing operations. Two types of valve-sparing operations
were performed: reimplantation of the aortic valve in 39 patients and remodeling of
the aortic root in 22 patients. Echocardiography was performed annually during
follow-up. The mean follow-ups were 75  54 months for the aortic root replace-
ment group and 49  38 months for the aortic valve-sparing group.
Results: There were 1 early death and 7 late deaths; 6 deaths were in the aortic root
replacement group and 2 were in the aortic valve-sparing group. Survivals at 10
years were 87% in the aortic root replacement group and 96% in the aortic
valve-sparing group (P  .3). Freedoms from reoperation at 10 years were 75% in
the root replacement group and 100% in the valve-sparing group (P .1). Freedoms
from valve-related mortality and morbidity were 65% after root replacement and
100% after valve-sparing operation (P  .02). Freedom from aortic insufficiency
greater than 2 after aortic valve-sparing operations was 75% at 10 years and was
similar for both types of valve-sparing operations; however, the diameters of the
aortic annulus and neoaortic sinuses increased only after the remodeling procedure.
Conclusions: This study suggests that aortic valve-sparing operations provide sim-
ilar survival but lower rates of valve-related complications than aortic root replace-
ment for patients with Marfan syndrome. Reimplantation of the aortic valve may be
more appropriate than remodeling of the aortic root to prevent dilation of the aortic
annulus, and for this reason we now use only this technique to treat patients with
Marfan syndrome.
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Until recently, composite replacement ofthe aortic valve and ascending aorta wasthe standard operation for aortic root an-eurysm in patients with Marfan syn-drome.1 In the early 1990s two types ofaortic valve-sparing operations were in-
troduced to repair aortic root aneurysms: reimplantation of
the aortic valve and remodeling of the aortic root.2,3 Al-
though these operations were rapidly incorporated into prac-
tice by some surgeons,4-6 others remained skeptical, partic-
ularly for patients with Marfan syndrome because of
abnormal fibrillin in the aortic cusps.1,7 Abnormal fibrillin is
also present in the leaflets of myxomatous mitral valve,7
however, and yet the durability of mitral valve repair in this
entity has been excellent.8
It remains unknown whether aortic valve-sparing opera-
tions are better than aortic root replacement for patients with
Marfan syndrome.1,9 It is also unknown what type of aortic
valve-sparing procedure is best suited for patients with
Marfan syndrome.4-6,9-12 It has been suggested that the re-
modeling procedure may better preserve aortic cusp motion,
theoretically enhancing the durability of the repair.11,12 Con-
versely, patients with Marfan syndrome often have annu-
loaortic ectasia, which genetic substrate probably has a
temporal expression, and the aortic annulus may dilate after
the remodeling procedure, with consequent failure of the
repair. This study examines the clinical results of both types
of aortic root surgery in patients with Marfan syndrome and
compares the early and late echocardiographic findings of
two types of aortic valve-sparing operation.
Patients and Methods
Cases of all patients operated on for aortic root aneurysm in our
institution with the diagnosis of Marfan syndrome according to the
Gent criteria13 were reviewed. Pediatric patients are not operated
on in our hospital, but an exception was made for a 12 year-old
boy. There were 105 patients: 44 underwent aortic root replace-
ment, and 61 underwent aortic valve-sparing operations. Aortic
root replacement was performed throughout the period of study,
which extended from 1979 to 2001, whereas aortic valve-sparing
operations were performed from 1988 to 2001.
Table 1 shows the clinical profiles of these two groups of
patients. All patients underwent transthoracic echocardiography
before surgery. Coronary angiography was performed in older
patients.
Operative Procedures
Aortic root replacement with a valved conduit was performed in 44
patients. The coronary arteries were reimplanted with the button
technique. Mechanical valves were used in 26 patients, aortic
valve homografts were used in 9, and bioprosthetic valves were
used in 9. The mitral valve was replaced in 7 patients and repaired
in 4. Coronary artery bypass grafting was performed in 5 patients.
The transverse aortic arch was replaced in 2 patients.
Since 1988, aortic valve-sparing operations were performed
whenever the aortic cusps were normal or amenable to repair. Two
techniques, reimplantation of the aortic valve and remodeling of
the aortic root, were initially used without any particular selection
criterion, but only the first procedure was used during the last 2
years of the study period. Technical details of these operations
have been published elsewhere.14,15 Reimplantation of the aortic
valve was used in 39 patients and remodeling of the aortic root was
used in 22. Age, functional class, size of the aortic root, severity of
aortic insufficiency (AI), and ventricular function were identical in
these two subgroups, but all patients with acute type A aortic
dissection had the reimplantation technique. Six patients (4 in the
reimplantation subgroup and 2 in the remodeling subgroup) un-
derwent repair of elongated aortic cusps with a double layer of a
6-0 expanded polytetrafluoroethylene suture.15 The mitral valve
was repaired in 8 patients (4 in the reimplantation subgroup and 4
in the remodeling subgroup). The transverse arch was replaced in
1 patient who underwent the remodeling procedure, and coronary
artery bypass grafting was performed in 4 patients, 2 from each
subgroup.
Echocardiography
Intraoperative transesophageal echocardiography was used in all
patients who underwent aortic valve-sparing operations. A trans-
thoracic study was also performed before discharge from hospital.
The first postoperative and most recent echocardiographic studies
were analyzed, and the offline measurements of the aortic annulus,
the neoaortic sinuses, and the aortic graft diameters from these two
examinations were compared. The diameter of the neoaortic si-
nuses was measured approximately 1.5 cm above the aortic annu-
lus. All measurements were performed during diastole and are
presented as the mean value of two consecutive cardiac cycles.
Morphologic assessment of the aortic cusps included extent and
degree of calcification and thickening. AI was estimated as none
(grade 0), trivial (grade 1), mild (grade 2), moderate (grade 3), or
severe (grade 4) on the basis of information from color flow
mapping and continuous-wave Doppler echocardiography.16,17
Follow-up
Patients were seen annually by the referring cardiologist, and
ongoing records were maintained in our Adult Congenital Heart
Clinic. Echocardiography was performed annually. For this study
follow-up was closed on February 28, 2002, and was 100% com-
plete. The mean follow-ups were 75 54 months for patients who
underwent aortic root replacement and 49  38 months for pa-
tients who underwent aortic valve-sparing operations (P  .01).
The mean follow-ups were 44  43 months for patients with the
reimplantation technique and 63  24 months for those with the
remodeling procedure (P  .05).
Statistical Analysis
Comparisons between the two main groups and subgroups were
made with unpaired t tests for continuous variables and 2 or
Fisher exact tests for categoric variables. Estimates for long-term
survival or freedom from morbid events were made by the Kaplan-
Meier method. Differences between survival curves were evalu-
ated with the log-rank statistic.
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There was 1 operative death, that of a patient who under-
went aortic root replacement. He was in cardiogenic shock
secondary to end-stage AI before the operation and died of
intractable heart failure.
Nine patients required reexploration of the mediastinum
for bleeding, 4 with aortic root replacement and 5 with
aortic valve-sparing operations (3% in the reimplantation
subgroup and 18% in the remodeling subgroup, P  .01).
Two patients who underwent aortic root replacement had
strokes, with complete neurologic resolution. Blood trans-
fusion or blood products were needed in 32% of patients
who underwent aortic root replacement and in 23% of those
who underwent aortic valve-sparing operations. There were
no cases of wound infection, myocardial infarction, renal or
respiratory failure, or any other postoperative complication.
There were 7 late deaths, 5 in the aortic root replacement
group and 2 in the aortic valve-sparing group. The deaths in
the aortic root replacement group were due to rupture of the
false lumen in 2 patients, congestive heart failure in 1
patient, prosthetic valve endocarditis in 1 patient, and com-
TABLE 1. Clinical profile of patients with Marfan syndrome
Variable Root replacement Valve sparing P value
No. of patients 44 61
Sex (No.) .2
Male 35 (79%) 46 (75%)
Female 9 (21%) 15 (25%)
(Age, y) .7
Mean  SD 34 11 35 10
Range 19-75 12-59
Timing of surgery (No.) .02
Elective 28 (64%) 45 (74%)
Urgent 11 (25%) 3 (5%)
Emergency 5 (11%) 9 (15%)
Congestive heart failure (No.) 15 (34%) 2 (3%) .001
Previous cardiac surgery (No.)
Total 13 (29%) 1 (2%) .001
Aortic valve replacement 8 (18%) 0
Aortic valve repair 2 (5%) 0
Mitral valve replacement 1 0
Mitral valve repair 1 0
Replacement of ascending aorta (No.) 1 1 .001
New York Heart Association functional class (No.) .001
I 9 (20%) 45 (74%)
II 9 (20%) 5 (8%)
III 10 (23%) 4 (7%)
IV 16 (36%) 7 (11%)
Echocardiographic and angiographic data
Left ventricular ejection fraction (No.) .001
Normal 19 (43%) 52 (85%)
Mild impairment 9 (20%) 8 (13%)
Moderate impairment 10 (23%) 0
Severe impairment 2 (4%) 0
Unknown 4 (9%) 1
Active infective endocarditis (No.) 4 (9%) 0 .02
Type A aortic dissection (No.) .0
Acute 6 (14%) 9 (15%)
Chronic 4 (9%) 0
Bicuspid aortic valve (No.) 4 (9%) 0 .1
Aortic root diameter (mm, mean  SD) 62 14 54 8 .001
Mitral regurgitation (No.) 10 (23%) 7 (11%) .05
AI (No.) .001
Trace (1) 5 (11%) 27 (44%)
Mild (2) 6 (14%) 19 (31%)
Moderate (3) 13 (29%) 9 (15%)
Severe (4) 20 (45%) 6 (10%)
Coronary artery disease (No.) 5 (11%) 4 (7%) .4
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plications of vertebral column surgery in 1 patient. The 2
deaths in the aortic valve-sparing group were due to acute
type B aortic dissection with rupture in 1 case and chronic
obstructive lung disease in 1 case. Figure 1 shows the
survivals of both groups of patients; at 10 years the surviv-
als were 87%  7% in the aortic root replacement group
and 96%  3% in the aortic valve-sparing group (P  .3).
There were 2 late strokes in patients who underwent
aortic root replacement; both patients recovered completely.
There were no strokes or transient ischemic attacks in
patients who underwent aortic valve-sparing operations.
The 10-year freedoms from thromboembolic events were
93%  5% after aortic root replacement and 100% after
aortic valve-sparing operations (P  .1).
There were 4 episodes of prosthetic valve endocarditis in
3 patients who underwent aortic root replacement. One
patient, whose condition was deemed inoperable, died. He
was an elderly man who had undergone aortic root and
mitral valve replacement twice before and had multiple
comorbid conditions. The other 2 patients underwent reop-
erative aortic root replacement (1 patient had 2 reoperations
4 years apart) and survived. The 10-year freedom from
prosthetic valve endocarditis after aortic root replacement
was 88%  7%. One paraplegic patient who underwent an
aortic valve-sparing operation acquired infective endocardi-
tis with an aortic root abscess with Streptococcus faecalis
11 years after the operation. He underwent aortic root re-
placement with a homograft and survived.
Five patients required reoperative aortic root replace-
ment, and 2 of them underwent this twice. Three reopera-
tions (in 2 patients) were because of prosthetic valve endo-
carditis and 4 reoperations (in 3 patients) were because of
biologic valve failure. Only 1 patient who underwent an
aortic valve sparing-operation needed aortic root replace-
ment for an aortic root abscess 11 years after the operation.
This patient had undergone the remodeling procedure. Fig-
ure 2 shows the freedom from aortic root reoperation. The
10-year freedoms from reoperation on the aortic root were
75%  9% for patients who underwent aortic root replace-
ment and 100% for those who underwent aortic valve-
sparing operations (P  .01). For the 26 patients who
underwent aortic root replacement with mechanical valves,
the freedom from reoperation was 92%  6%.
Figure 3 shows the freedoms from valve-related mortal-
ity and morbidity in both groups of patients. At 10 years,
65%  10% of patients who underwent aortic root replace-
ment and 100% of patients who underwent aortic valve-
sparing operations were free from any complications (P 
.02). Among the 26 patients who underwent aortic root
replacement with mechanical valves, the freedom from
valve-related mortality and morbidity was 87%  7%.
Four patients, 2 from each group, with chronic type A
Figure 1. Kaplan-Meier estimates of survival in patients with
Marfan syndrome after aortic valve-sparing operations (solid
line) or aortic valve replacement (dashed line).
Figure 2. Freedoms from reoperation on aortic valve in patients
with Marfan syndrome after aortic valve-sparing operations (sol-
id line) or aortic valve replacement (dashed line).
Figure 3. Freedoms from any valve-related mortality or morbidity
in patients with Marfan syndrome after aortic valve-sparing op-
erations (solid line) or aortic valve replacement (dashed line).
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aortic dissections required replacement of the entire thoracic
and abdominal aorta because of expansion or rupture of the
false lumen. One patient died, and 1 (the same who had
endocarditis after an aortic valve-sparing operation) became
paraplegic; the other 2 did well. A fifth patient, this one in
the aortic root replacement group, needed repair at another
institution of a false aneurysm at the right coronary artery
reimplantation site.
Echocardiography After Aortic Valve-Sparing
Operations
Table 2 shows AI grades early and late after the operation in
patients who underwent aortic valve-sparing operations.
Figure 4 shows freedom from AI greater than 2 for all
patients who had aortic valve sparing. Figure 5 shows the
freedoms from AI greater than 2 in the two subgroups
through 8 years only because of the small number of pa-
tients at risk.
The early and late diameters of the aortic annulus (25 
3 and 26  3 mm, respectively), neosinuses of Valsalva
(31  4 and 31  5 mm, respectively), and sinotubular
junction (28  4 and 29  4 mm, respectively) remained
unchanged in patients who underwent reimplantation of the
aortic valve. The diameters of the aortic annulus and neo-
aortic sinuses increased in patients who underwent remod-
eling of the aortic root, as shown in Table 3. As expected,
the diameter of the sinotubular junction did not change.
Although there was an increase in annular diameter in the
entire subgroup from 23.1 to 24.8 mm, annular diameter did
not change in 11 patients and increased by 10% or more in
10 patients. Aortic annuloplasty had no effect on annular
dilation. Ten patients underwent aortic annuloplasty, and
the annulus was dilated by 10% or more in 6 of them.
Neoaortic sinus diameter increased in all patients, but it
increased by more than 20% in 10 of them; in those 10
patients the aortic annulus was also dilated. We could not
establish a relationship between the degree of postoperative
dilation of the aortic annulus and the severity of AI in
patients who underwent remodeling of the aortic root. In all
patients, regardless of the type of aortic valve sparing-
operation, the aortic cusps remained thin and pliable.
Discussion
Without surgery most patients with Marfan syndrome die in
the third decade of their lives from complications of aortic
root aneurysm, such as aortic rupture, aortic dissection, and
AI.18,19 Aortic root replacement dramatically improves the
survival of these patients.1 In a recent report by Gott and
associates20 on the results of aortic root replacement in 271
patients with Marfan syndrome, there was no operative
mortality among 235 patients operated on electively, and
operative mortality was only 5.6% among 36 patients op-
erated on urgently. Twenty-four patients who underwent
aortic valve-sparing operations were included in that study.
The 5- and 10-year survivals was 89% and 81%, respec-
tively. One suspects that most patients received mechanical
heart valves and required anticoagulation with warfarin
sodium. Only 2 patients died as consequence of oral anti-
coagulation therapy. At 10 years the freedom from throm-
boembolic complications was 93%. These rates of throm-
boembolic and hemorrhagic events are certainly lower than
in other reports on aortic valve replacement with mechani-
cal valves.21,22 The differences could be due to the young
age of patients with Marfan syndrome and to other anatomic
factors, such as the absence of suture knots on the sewing
ring of commercially available valved conduits. Eleven
patients had endocarditis develop, and the freedom from
prosthetic valve endocarditis was 94% at 10 years.20 The
results of aortic root replacement in our series were similar
to those reported by Gott and associates.20 Dysrhythmias
(possibly sudden death), dissection or rupture of the remain-
Figure 4. Freedom from AI greater than 2 in patients with
Marfan syndrome after aortic valve–sparing operations.
Figure 5. Freedoms from AI greater than 2 in patients with
Marfan syndrome after reimplantation of aortic valve (dashed
line) and remodeling of aortic root (solid line).
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ing aorta, and valve-related complications were the princi-
pal causes of death in Gott and colleagues’ study20 as well
as in our patients.1
The results of aortic valve-sparing operations in patients
with Marfan syndrome have been excellent in our institu-
tion. Although the long-term survival of these patients was
similar to that of patients who underwent aortic root re-
placement, there was a higher freedom from valve-related
morbidity and mortality after aortic valve-sparing opera-
tions than after aortic root replacement, as shown in Figure
3. It is unlikely that the preoperative differences in clinical
profile accounted for these differences in outcomes. The
lack of anticoagulation and the lower incidence of endocar-
ditis may account for some of the differences. We firmly
believe that the aortic valve, as well as the mitral valve,
should be preserved whenever possible in patients with
Marfan syndrome. We consider aortic root replacement and
aortic valve-sparing operations not as competitive proce-
dures but as complementary procedures. Aortic valve-spar-
ing procedures should be reserved for patients who have
normal aortic cusps, whereas aortic root replacement should
be used for those who have abnormal aortic cusps.
We began to perform aortic valve-sparing operations in
patients with aortic root aneurysms in 1988. Since then we
have replaced the aortic root only if the aortic cusps are
abnormal. We started with the reimplantation technique but
soon began to use the remodeling procedure because of the
theoretic importance of recreating aortic sinuses.4,12 Later
we added an aortic annuloplasty to the remodeling proce-
dure in patients with annuloaortic ectasia or Marfan syn-
drome in the hopes of preventing future dilation of the aortic
annulus.14 Although the results of both procedures have
been satisfactory, we believe that the aortic annulus dilates
in a large proportion of patients with Marfan syndrome who
had an annulus of normal diameter at the time of surgery.
Indeed, we documented a significant increase in the diam-
eter of the aortic annulus in half of 22 patients who under-
went remodeling of the aortic root. To our surprise, aortic
annuloplasty had no effect on the late dilation, probably
because the connective tissue between suture lines dilated or
the annuloplasty sutures slowly cut through the abnormal
fibrous tissue of the left ventricular outflow tract. We could
not establish a relationship between dilation of the aortic
annulus and the development of AI in our patients, probably
because of a small sample size. As shown in Figure 5 and in
Table 3, however, reimplantation of the aortic valve appears
to be more stable as far as the lack of AI is concerned.
In a report by Birks and coworkers23 on 82 patients with
Marfan syndrome who underwent the remodeling proce-
dure, the 10-year survival was 84%, and the freedom from
reoperation on the aortic root was 83%. At the latest fol-
low-up of patients who were alive without reoperation, 22%
had moderate AI. Although no information was given re-
garding the mechanism of AI, it is conceivable that most
failures were due to late dilation of the aortic annulus, because
only 2 patients had moderate AI soon after the operation.
The technique of reimplantation of the aortic valve pre-
vents annular dilation because the entire aortic valve is
secured inside a tubular Dacron graft. The main shortcom-
ing of this technique is the elimination of the sinuses of
Valsalva, which may be important for normal cusp motion
and durability.4,12 This may be true, but it has not become
evident during the first decade of follow-up. It is possible to
create neoaortic sinuses with the reimplantation technique.
All that is required is to use graft larger than needed and
tailor it as the operation is done. The diameter of the graft
is first reduced at the level where it is secured to the left
ventricular outflow tract. Then, after the aortic valve is
resuspended inside the graft, the spaces between commis-
sures are plicated to reduce the diameter of the sinotubular
junction as desired at the same time as the neoaortic sinuses
are created. One may also use a graft with neoaortic sinuses,
TABLE 2. AI after aortic valve-sparing operations
Remodeling (n  22) Reimplantation (n  39)
Early Late Early Late
None or trivial 16 (73%) 7 (32%) 27 (70%) 25 (64%)
Mild 6 (27%) 11 (50%) 12 (20%) 12 (31%)
Moderate 0 3 (14%) 0 2 (5%)
Severe 0 1 (4%) 0 0
TABLE 3. Echocardiographic measurements after remodeling of the aortic root
Diameter (mm) Early Late Change P value
Aortic annulus 23.1 1.6 24.8 1.9 1.7 0.4 .0001
Neoaortic sinuses 30.2 4.1 35.3 5.0 5.1 0.7 .0001
Sinotubular junction 26.8 1.5 27.7 2.9 0.9 0.6 .1121
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which has been developed by De Paulis and associates24 and
is now commercially available. We prefer, however, to
tailor our own.
Limitations of the Study
Both aortic root replacement and aortic valve-sparing oper-
ations are complex procedures, and probably numerous
variables play a role in their outcomes. The sample sizes in
this study are too small for a more comprehensive analysis.
In addition, because of the small number of patients who
underwent aortic valve-sparing operations who were at risk
at late follow-up, we may have underestimated the inci-
dence of late AI.
Conclusions
The results of aortic valve-sparing operations in patients
with Marfan syndrome have been excellent during the first
decade. Valve function appears to deteriorate with time in
some patients, which may reflect imperfect techniques or
incorrect surgical adjustments of the various components of
the aortic root during these reconstructive procedures. Re-
implantation of the aortic valve may allow a more stable
aortic valve function than does remodeling of the aortic
root. Creation of neoaortic sinuses during aortic valve-
sparing operations may enhance function and durability of
the aortic valve.
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Discussion
Sir Magdi Yacoub (London, United Kingdom). I congratulate
de Oliveira and colleagues from Toronto for an excellent presen-
tation and thank them for sending me the text for review. This
report concerns a single-center retrospective study of patients
undergoing either repair or replacement of the aortic root. The
authors reported what they described as excellent survival for both
the repair and the replacement groups, with 96% and 87% esti-
mated survivals at 10 years, respectively. They also confirmed that
patients undergoing replacement did have complications inherent
to the use of artificial valves, even though the incidence was
slightly lower than in isolated valve replacement, and they spec-
ulated that this might be due to the absence of knots inside the
aorta. They then compared the two types of valve-sparing opera-
tions and found that there were no differences in survival or valve
function, at least in the text that I saw, but there was a difference
in terms of a tendency toward dilatation of the sinuses, but not so
much the annulus, after the remodeling operation. I have several
questions and one comment.
The first question relates to the pattern of survival, with 10-year
survivals of 96% and 87%. Although statistically there was not a
significant difference, the lack of significance was probably, as
indicated in the text, due to the small number of repair patients,
with only 2 patients followed up for 10 years. If this trend were to
continue, however, it might become significant, and we do look
forward to further reports about this. The second question related
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to the pattern of survival is whether de Oliveira and colleagues
have considered, in view of the very young age of these patients,
comparing this pattern of survival with age-matched control sub-
jects from the general population?
The next question relates to the indication for operation. What
were the incidences of acute and chronic dissection in this series?
This could have an important bearing on both the early and
long-term results. In a previously reported series of patients with
Marfan syndrome undergoing repair at our center, we observed an
incidence of 35% of dissection, which did indeed influence both
the early and long-term results. So I would like to know whether
de Oliveira and colleagues looked at that. Equally, did they con-
sider prophylactic repair, particularly in view of the very good
results, for high-risk patients with aneurysms of the aortic root
before there is significant regurgitation? Prophylaxis might be
particularly relevant for patients known to be at high risk, as
indicated by several prognostic indicators. This could avoid dis-
section, which is catastrophic, both in the early and longer term. It
could also, importantly, halt the progressive changes in the cusps,
because aortic regurgitation has been shown to increase the
amount of matrix metalloproteinases, which cause the cusps to
shrink. What was the cutoff point in terms of size, if prophylactic
repair was indeed used?
Another point has to do with endocarditis. The authors stated
that there was no incidence of endocarditis and that there were no
reoperations in the repair group, but then somewhere else in the
article they did mention that a patient with repair required replace-
ment of the root. How do they reconcile those two statements?
Also, what was the indication for the use of a prosthetic valve, a
homograft, or an unstented xenograft? Was there a rationale be-
hind the choice?
In a larger series from our center of remodeling operations, we
have confirmed the results of this study. In particular, we have seen
that the results depend critically on timing of the operation but
equally, as de Oliveira and colleagues stress in the article, on
technical details. For example, during the last 4 years or so we
have introduced several technical refinements in the remodeling
operation. The first is undersizing of the graft, which we think is
really important; the second is insertion of the top of the commis-
sures within the Dacron polyester fabric graft. The third, which is
probably the most important, is in the length and shape of the
tongues of the Dacron polyester fabric tube, which we think should
be as long as possible and tapering at its end. This has the effect
of remodeling of the sinuses. By the way, all the diseased aortic
wall is excised in the remodeling operation. This is essential, and
the stitches have to be in the annulus. But a thin, long tongue
would reshape the sinuses and form a vortex, which in effect
pushes the bottom of the sinuses inward.
Dr de Oliveira. Starting with the first question, yes, we believe
that with a larger sample size the difference in survival between
root replacement and valve sparing operations will become signif-
icant. The lower risk of infective endocarditis and the absence of
anticoagulation therapy after preservation of the native valve are
important factors associated with lower morbidity and mortality
after valve-sparing operations.
We did not attempt to match the patients in this study with the
general population to compare the long-term survival because of
the relatively small sample size.
As far as aortic dissection is concerned, there were 15 cases of
acute aortic dissection; 9 of these patients had undergone valve-
sparing operations with reimplantation of the aortic valve and 6
had undergone root replacement. We believe that reimplantation of
the aortic valve gives a more stable repair and is associated with a
lower risk of postoperative bleeding. There were 4 chronic dissec-
tions, and these patients all had undergone root replacement.
Regarding prophylactic surgery in high-risk patients, such as
female patients during child-bearing age and patients with a family
history of aortic dissection, we tend to be more aggressive and to
recommend repair when the root reaches 45 mm, whereas we use
50 mm to recommend surgery in other patients. We should try to
avoid dissection and aortic complications in this very young group
of patients because of the negative effect on operative mortality
and long-term survival. In most series, including ours, an impor-
tant cause of late death has been rupture of the false lumen. In our
series 4 patients required reoperation on the residual aorta because
of expansion or rupture of the false lumen. One patient died, and
1 had paraplegia develop.
With respect to the issue of infective endocarditis, there were 5
episodes of endocarditis: 4 after root replacement and 1 after
remodeling. The latter occurred 11 years after the operation. That
is why the freedom from endocarditis was 100% at 10 years.
Finally, I can only speculate on the indications for using ho-
mograft or bioprosthetic valves. They probably were used because
the patients did not wish to take anticoagulant. I thank you again
for your comments and questions.
Dr Hartzell V. Schaff (Rochester, Minn). Technique is terribly
important, but did you look at the outcome related to the degree of
preoperative aortic valve regurgitation? What degree of preopera-
tive aortic regurgitation would make you hesitant to try to preserve
the valve?
Dr de Oliveira. There was a correlation between the size of the
aortic root and the probability of preserving the valve. If the root
was less than 5 cm in diameter, most cusps were normal. If the root
was between 5 and 6 cm, about 50% of them were normal. If the
aneurysm was more than 6 cm, then most cusps were abnormal,
and those patients were more likely to undergo aortic root replace-
ment. Is that the answer to your question?
Dr Schaff. Not directly. The question is the degree of aortic
valve regurgitation, understanding that the larger annuli will have
more leakage. Is there a degree of aortic valve regurgitation about
which you would worry?
Dr de Oliveira. We did not look at that specifically, but I
believe that the more severe the degree of AI, the less the chance
to repair the valves. The cusps will more likely become thinner and
fenestrated, making the repair more difficult and risky. However,
6 of our patients had prolapse of one cusp and yet were amenable
to repair with good results.
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